Summary
Pretraining i.p. administration of N-methyl-D-aspartic acid (NMDA) at doses of 10 and 20mg/kg dose-dependently facilitated performance in a water T-maze learning task in rats. The effect of NMDA was inhibited by the competitive NMDA receptor antagonist CGP37849 [(DL)-E(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid] (CGP) at a dose of 6mg/kg, and by the NMDA receptor complex glycine site antagonist 1-hydroxy-3-amino-2-pyrrolidone (HA-966) at a dose of 10mg/kg. The NMDA site antagonist, when given alone, did not impair learning. The glycine precursor milacemide (2-N-pentylaminoacetamide HCl), at doses of 5 and 10mg/kg accelearted learning acquisition and its effect was antagonized by HA-966. The learning rate was impaired following the administration of NMDA 10mg/kg together with milacemide 5mg/kg when compared with the effect of 10mg/kg NMDA alone.
The administration of 5mg/kg NMDA was associated with an elevated tissue concentration of aspartate in the hippocampus, an effect which was antagonized by 6mg/kg of CGP. NMDA at doses of 10 and 20mg/kg elevated the concentration of glycine but decreased the concentration of aspartate, glutamate and glutamine in the cortex and aspartate in the hippocampus. The cortical effects of NMDA 10mg/kg were antagonized by 6mg/kg of CGP. Milacemide at the dose of 10mg/kg elevated glycine, aspartate, glutamate and taurine concentrations. The coadministration of 5 mg/kg NMDA with 5mg/kg milacemide elevated the concentrations of glycine, glutamate and glutamine in the cortex and taurine in the hippocampus. These amino acid levels were higher than after administration of 5mg/kg either agent alone. The results demonstrate a dose-dependent facilitation effect on learning performance by NMDA and glycine receptor agonists. Antagonists at the NMDA and glycine sites counteracted the learning improvement of NMDA, and the glycine site antagonist the effect of milacemide.
Similar content being viewed by others
References
Bednar I, Södersten P, Qureshi GA (1992) A simple HPLC method in monitoring catecholamines, tryptophan, and their metabolites in CSF of rats: a role of dopamine and noradrenaline in food intake. J Liquid Chrom 15: 3087–3096
Benveniste M, Clements J, Vyklicky LJ, Mayer ML (1990) A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J Physiol (Lond) 428: 333–357
Bonhaus DW, Burge BC, McNamara JO (1987) Biochemical evidence that glycine allosterically regulates an NMDA receptor-coupled ion channel. Eur J Pharmacol 142: 489–490
Christophe J, Kutzner R, Nguyen-Bui ND, Damien C, Chatelain P, Gillet L (1983) Conversion of orally administered 2-N-pentylaminoacetamide into glycinamide and glycine in the rat brain. Life Sci 33: 533–541
Collingridge GL, Bliss TVP (1987) NMDA receptors — their role in long-term potentiation. Trends Neurosci 10: 288–293
Danysz W, Wroblewski J, Brooker G, Costa E (1989) Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Brain Res 479: 270–276
Dunn RW, Flanagan DM, Martin LL, Kerman LL, Woods AT, Camacho F, Wilmot CA, Cornfeldt ML, Effland RC, Wood PL, Corbett R (1992) Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur J Pharmacol 214: 207–214
Fadda E, Danysz W, Wroblewski JT, Costa E (1988) Glycine and D-serine increase the affinity of N-methyl-D-aspartate sensitive glutamate binding sites in rat brain synaptic membranes. Neuropharmacology 27: 1183–1185
Fagg GE, Olpe H-R, Pozza MF, Baud J, Steinmann M, Schmutz M, Portet C, Baumann P, Thedinga K, Bittiger H, Allgeier H, Heckenhorn R, Angst C, Brundish D, Dingvall JG (1990) CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br J Pharmacol 99: 791–797
Flood JF, Baker ML, Davis JL (1990) Modulation of memory processing by glutamic receptor agonists and antagonists. Brain Res 521: 197–202
Girault JA, Barbeito L, Spampinato U, Gazlan H, Glowinski J, Besson MJ (1986) In vivo release of endogenous amino acids from the rat striatum: further evidence for a role of glutamate and aspartate in corticostriatal neurotransmission. J Neurochem 47: 98–106
Handelmann GE, Nevins ME, Mueller LL, Arnolde SM, Cordi AA (1989) Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents. Pharmacol Biochem Behav 34: 823–828
Harris EW, Ganong AH, Cotman CW (1984) Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res 323: 132–137
Hutson, PH, Bristow LJ, Thorn L, Tricklebank MD (1991) R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br J Pharmacol 103: 2037–2044
Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 329–331
Kaplita PV, Ferkany JW (1990) Evidence for direct interactions between the NMDA and glycine recognition sites in brain. Eur J Pharmacol 188: 175–179
Kemp JA, Priestley T (1991) Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons. Mol Pharmacol 39: 666–670
Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with the NMDA receptors: Characterization and identification of new class of antagonists. J Neurochem 52: 1319–1328
Kleckner NW, Dingledine R (1988) Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241: 835–837
Krebs M-O, Kemel M, Gauchy C, Desban M, Glowinski J (1989) Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum. Eur J Pharmacol 166: 567–570
Lehman A, Isacsson H, Hamberger A (1983) Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J Neurochem 40: 1314–1320
Maj J, Skuza G, Rogoz Z (1993) Some central effects of CGP37849 and CGP39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J Neural Transm 6: 53–62
Monaghan DT, Cotman CW, Olverman HJ, Watkins JC (1988a) Two classes of NMDA recognition sites: differential distribution and regulation by glycine. In: Canalheiro EA, Lehman J, Turski L (eds) Frontiers in excitatory amino acid research. Alan R Liss, New York, pp 543–550
Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW (1988b) Two classes of N-methyl-D-aspartate recognition sites: Differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 85: 9836–9840
Monahan JB, Corpus VM, Hood WF, Thomas JW, Compton RP (1989) Characterization of a [3H]glycine recognition site as a modulatory site if the N-methyl-D-aspartate receptor complex. J Neurochem 53: 370–375
Mondadori C, Weizkrantz L, Buerki H, Petschke F, Fagg GE (1989) NMDA receptor antagonists can enhance or impair learning performance in animals. Exp Brain Res 75: 449–456
Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomelli H, Burmashev N, Sakman B, Seeburg PH (1992) Heterometric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217–1221
Mugnaini M, Giberti A, Ratti E, van Amsterdam F (1993) Allosteric modulation of [3H]CGP39653 binding by glycine in rat brain. J Neurochem 61: 1492–1497
O'Brien EM, Tipton KF, Strolin Benedetti M, Bonsignori A, Marrari P, Dostert P (1989) Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions. Biochem Pharmacol 41: 1731–1737
Quartermain D, Nuygen T, Sheu J, Herting RL (1991) Milacemide enhances memory storage and alleviates spontaneous forgetting in mice. Pharmacol Biochem Behav 39: 31–35
Qureshi GA, Baig SM (1993) Application of high performance liquid chromatography in study of sulphur amino acid metabolism in uremic patients. Biochem Mol Int 29: 359–368
Ransom RW, Deschenes NL (1990) Polyamines regulate glycine interaction with the N-methyl-D-aspartate receptor. Synapse 5: 294–298
Saletu B, Grünberger J (1984) Early clinical pharmacological trials with a new antiepileptic, milacemide, using pharmaco-EEG and psychometry. Met Find Exp Clin Pharmacol 6: 317–330
Saletu B, Grünberger J, Linzmayer L (1986) Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations. Arch Gerontol Geriatr 5: 165–181
Scholfield CN, Moroni F, Corradetti R, Pepeu G (1983) Levels and synthesis of glutamate and aspartate in the olfactory cortex following bulbectomy. J Neurochem 41: 135–238
Schwartz BL, Hashtroudi S, Herting RL, Deutsch S (1992) The effects of milacemide on item and source memory. Clin Neuropharmacol 15: 114–119
Shibanoki S, Kogure M, Sugahara M, Ishikawa K (1993) Effect of systemic administration of N-methyl-Daspartic acid on extracellular taurine level measured by microdialysis in the hippocampal CA1 field and striatum of rats. J Neurochem 61: 1698–1704
Singh L, Oles RJ, Tricklebank MD (1990) Modulation of seizure susceptibility in the mouse by strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. Br J Pharmacol 99: 285–288
Szerb JC, O'Regan PA (1985) Effect of glutamine on glutamate release from hippocampal slices induced by high K+ or by electrical stimulation: interaction with different Ca++ concentrations. J Neurochem 44: 1724–1731
Thomson A, Walker V, Flynn D (1989) Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature 338: 422–424
Weizkranz L, Mondadori C (1991) MK-801 can facilitate passive avoidance memory when retention is not present in control animals, and fail to facilitate when it is present. Psychopharmacology 105: 145–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liljequist, R. Glycine modulates N-methyl-D-aspartic acid induced learning facilitation in rats. Amino Acids 10, 345–358 (1996). https://doi.org/10.1007/BF00805862
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00805862